logo
Apogee Therapeutics price target raised to $115 from $100 at BTIG

Apogee Therapeutics price target raised to $115 from $100 at BTIG

BTIG raised the firm's price target on Apogee Therapeutics (APGE) to $115 from $100 and keeps a Buy rating on the shares. The firm notes that the new EASI-75 watermark for Biologics in Atopic Dermatitis exceeded its expectations and supports a market-leading profile, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Jefferies Sticks to Their Buy Rating for Otsuka Holdings Co (OTSKF)
Jefferies Sticks to Their Buy Rating for Otsuka Holdings Co (OTSKF)

Business Insider

time39 minutes ago

  • Business Insider

Jefferies Sticks to Their Buy Rating for Otsuka Holdings Co (OTSKF)

Jefferies analyst Stephen Barker maintained a Buy rating on Otsuka Holdings Co today and set a price target of Yen9,500.00. The company's shares closed last Tuesday at $44.40. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Barker covers the Healthcare sector, focusing on stocks such as Sumitomo Dainippon Pharma Co, Otsuka Holdings Co, and Astellas Pharma. According to TipRanks, Barker has an average return of 6.3% and a 48.57% success rate on recommended stocks. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Otsuka Holdings Co with a $60.62 average price target, implying a 36.53% upside from current levels. In a report released on July 15, J.P. Morgan also maintained a Buy rating on the stock with a Yen11,000.00 price target.

Jefferies Keeps Their Buy Rating on Manulife Financial (MFC)
Jefferies Keeps Their Buy Rating on Manulife Financial (MFC)

Business Insider

time3 hours ago

  • Business Insider

Jefferies Keeps Their Buy Rating on Manulife Financial (MFC)

Jefferies analyst John Aiken maintained a Buy rating on Manulife Financial today and set a price target of C$49.00. The company's shares closed last Friday at $30.82. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Aiken covers the Financial sector, focusing on stocks such as Bank Of Montreal, Bank Of Nova Scotia, and Canadian Bank of Commerce. According to TipRanks, Aiken has an average return of 0.3% and a 51.83% success rate on recommended stocks. Manulife Financial has an analyst consensus of Moderate Buy, with a price target consensus of $38.79, a 25.86% upside from current levels. In a report released yesterday, TR | OpenAI – 4o also reiterated a Buy rating on the stock with a C$48.00 price target. MFC market cap is currently $52.74B and has a P/E ratio of 16.02. Based on the recent corporate insider activity of 149 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of MFC in relation to earlier this year.

Macquarie Remains a Hold on Indian Hotels Co. Ltd. (INDHOTEL)
Macquarie Remains a Hold on Indian Hotels Co. Ltd. (INDHOTEL)

Business Insider

time3 hours ago

  • Business Insider

Macquarie Remains a Hold on Indian Hotels Co. Ltd. (INDHOTEL)

In a report released on July 18, Sameet Sinha from Macquarie maintained a Hold rating on Indian Hotels Co. Ltd., with a price target of INR800.00. The company's shares closed last Friday at INR766.20. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Sinha is a 5-star analyst with an average return of 13.8% and a 51.75% success rate. Indian Hotels Co. Ltd. has an analyst consensus of Strong Buy, with a price target consensus of INR895.20. The company has a one-year high of INR894.15 and a one-year low of INR574.00. Currently, Indian Hotels Co. Ltd. has an average volume of 130.6K.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store